Ainos (AIMD) Issues Mid-Year Business Update Letter to Shareholders
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall St mixed as Middle East tensions eclipse tech strength
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Ainos Issues Mid-Year Business Update Letter to Shareholders
June 27, 2023 8:32 AM EDTCompany ramping up marketing of VELDONA Pet and aiming to complete clinical trials in Taiwan of its flagship AI Nose-powered POCT by the end of 2023
Ainos sees VELDONA Pet and AI Nose-powered POCT as key drivers in transforming the company
SAN DIEGO, CA / ACCESSWIRE / June 27, 2023 / Ainos, Inc. (NASDAQ:AIMD, AIMDW) ("Ainos", or the "Company"), a diversified healthcare company focused on the development of novel point-of-care testing, low-dose interferon therapeutics, and synthetic RNA-driven preventative medicine, is pleased to provide a business update letter to shareholders from Ainos' Chairman of the Board,... More
